Identification of Lactylation-Related Diagnostic Biomarkers for Atherosclerosis via Integrative Transcriptomic and Machine Learning Analysis
This study identifies and validates four lactylation-related genes (KCNN4, PIK3CG, SLC25A4, and TPP1) as key diagnostic biomarkers and potential therapeutic targets for atherosclerosis through integrative transcriptomic analysis, machine learning modeling, and macrophage experimental verification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Heart disease remains the leading cause of death worldwide, and at the heart of this crisis lies a condition called atherosclerosis. This is a process where fatty plaques build up inside the arteries, narrowing the passageways for blood and potentially triggering heart attacks or strokes. Doctors currently rely on imaging scans and blood tests to spot these plaques, but these tools often struggle to detect the earliest, most subtle changes before a vessel becomes dangerously blocked. There is a pressing need for a way to see the disease earlier, perhaps by looking at the tiny chemical signals inside our cells that change long before a blockage becomes visible on a scan.
One such signal involves a process called lactylation. Cells produce a substance called lactate when they break down sugar for energy, especially when oxygen is low or inflammation is high. In recent years, scientists discovered that lactate does more than just sit in the cell; it can attach itself to proteins and alter how genes are turned on or off. This chemical attachment, known as lactylation, acts like a switch that changes cell behavior. In the context of heart disease, the environment inside a clogged artery is rich in fat and inflammation, creating the perfect conditions for this process to happen. Researchers suspect that the genes responding to these lactate signals could serve as early warning signs for atherosclerosis, offering a new way to diagnose the disease before it causes a catastrophe.
A team of researchers from hospitals and universities in China set out to find these specific genetic signals. They began by mining vast digital libraries of genetic data from patients with atherosclerosis and healthy individuals. Using powerful computer algorithms, they sifted through thousands of genes to find the ones that behaved differently in sick patients compared to healthy ones. They then narrowed this list further by focusing only on genes known to be influenced by lactate. This process of elimination, combined with a method that looks for groups of genes that work together like a team, allowed them to pinpoint four specific genes that stood out as the most important players in the disease. These genes are named KCNN4, PIK3CG, SLC25A4, and TPP1.
To ensure these computer findings were real and not just digital noise, the scientists moved into the laboratory. They took mouse immune cells, which are similar to the cells that build up in human arteries, and exposed them to a substance that mimics the fatty, inflamed environment of a diseased artery. When they measured the activity of the four genes in these cells, they found that all four became significantly more active, just as the computer models had predicted. This confirmed that these genes respond directly to the conditions found in atherosclerosis. The researchers then used advanced statistical models to test how well these four genes could distinguish between healthy people and those with the disease. The results showed that these genes could accurately identify the disease, with the computer models performing better than many existing diagnostic methods.
Among the four genes, one called TPP1 appeared to be particularly special. The team found that this gene had a strong connection to macrophages, a type of immune cell that acts as a scavenger in the body. In atherosclerosis, these macrophages become overloaded with fat and contribute to the growth of dangerous plaques. The study suggests that TPP1 helps regulate how these cells function and respond to the inflammatory environment. While the other three genes also played significant roles, TPP1 seemed to be a key driver in the immune response that fuels the disease. The researchers did not claim to have found a cure, but they did identify a set of biological markers that are tightly linked to the disease's progression.
The study concludes that these four lactate-related genes offer a promising new path for diagnosis. By measuring the levels of KCNN4, PIK3CG, SLC25A4, and TPP1, doctors might one day be able to detect atherosclerosis much earlier than current methods allow. The work highlights how a specific chemical process inside cells can be traced back to a major human disease, turning a complex biological mechanism into a potential tool for saving lives. While more research is needed to bring these findings to the clinic, the identification of these specific genetic markers provides a concrete target for future medical breakthroughs.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.